Recombinant Vaccines


The recombinant vaccine is developed through recombinant DNA technology. These Vaccines are produced by the insertion of genetic material which encodes the antigen that stimulates an immune response. Plasmid DNA is used as a vaccine which is propagated in bacteria like E.Coli and they get isolated and purified into the vaccine.


    Related Conference of Recombinant Vaccines

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    September 09-10, 2024

    7th International Conference on Vaccines and Immunology

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Recombinant Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in